Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Pyrotinib after trastuzumab-based adjuvant therapy in patients with HER2-positive breast cancer (PERSIST): A multicenter phase II trial

View ORCID ProfileFeilin Cao, Zhaosheng Ma, Zenggui Wu, Weizhu Wu, Ouchen Wang, Binbin Cui, Xiaotao Zhu, Jing Hao, Xiaochun Ji, Zhanwen Li, Deyou Tao, Qingjing Feng, Wei Lin, Dongbo Shi, Jingde Shu, Jichun Zhou, Shifen Huang
doi: https://doi.org/10.1101/2024.09.05.24313095
Feilin Cao
1Department of Thyroid and Breast Surgery, Taizhou Hospital of Zhejiang Province, Wenzhou Medical University, Taizhou, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Feilin Cao
  • For correspondence: drcfl{at}126.com
Zhaosheng Ma
1Department of Thyroid and Breast Surgery, Taizhou Hospital of Zhejiang Province, Wenzhou Medical University, Taizhou, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Zenggui Wu
1Department of Thyroid and Breast Surgery, Taizhou Hospital of Zhejiang Province, Wenzhou Medical University, Taizhou, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Weizhu Wu
2Department of Thyroid and Breast Surgery, Ningbo Medical Center Lihuili Hospital, Ningbo, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ouchen Wang
3Department of Breast Surgery, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Binbin Cui
1Department of Thyroid and Breast Surgery, Taizhou Hospital of Zhejiang Province, Wenzhou Medical University, Taizhou, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Xiaotao Zhu
4Department of Thyroid and Breast Surgery, Jinhua Municipal Central Hospital, Jinhua, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jing Hao
5Department of Thyroid and Breast Surgery, Yiwu Central Hospital, Jinhua, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Xiaochun Ji
2Department of Thyroid and Breast Surgery, Ningbo Medical Center Lihuili Hospital, Ningbo, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Zhanwen Li
6Department of Breast Surgery, Ningbo Women & Children’s Hospital, Ningbo, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Deyou Tao
1Department of Thyroid and Breast Surgery, Taizhou Hospital of Zhejiang Province, Wenzhou Medical University, Taizhou, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Qingjing Feng
7Department of Breast Surgery, Yiwu Maternity and Children Hospital, Jinhua, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Wei Lin
8Department of Surgical Oncology, Quzhou People’s Hospital, Quzhou, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dongbo Shi
9Department of Breast Surgery, The First Affiliated Hospital of Ningbo University, Ningbo, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jingde Shu
8Department of Surgical Oncology, Quzhou People’s Hospital, Quzhou, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jichun Zhou
10Department of Surgical Oncology, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Shifen Huang
1Department of Thyroid and Breast Surgery, Taizhou Hospital of Zhejiang Province, Wenzhou Medical University, Taizhou, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Data availability statement

Data supporting the findings of this study are available from the corresponding author upon reasonable request.

Back to top
PreviousNext
Posted December 27, 2024.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Pyrotinib after trastuzumab-based adjuvant therapy in patients with HER2-positive breast cancer (PERSIST): A multicenter phase II trial
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Pyrotinib after trastuzumab-based adjuvant therapy in patients with HER2-positive breast cancer (PERSIST): A multicenter phase II trial
Feilin Cao, Zhaosheng Ma, Zenggui Wu, Weizhu Wu, Ouchen Wang, Binbin Cui, Xiaotao Zhu, Jing Hao, Xiaochun Ji, Zhanwen Li, Deyou Tao, Qingjing Feng, Wei Lin, Dongbo Shi, Jingde Shu, Jichun Zhou, Shifen Huang
medRxiv 2024.09.05.24313095; doi: https://doi.org/10.1101/2024.09.05.24313095
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Pyrotinib after trastuzumab-based adjuvant therapy in patients with HER2-positive breast cancer (PERSIST): A multicenter phase II trial
Feilin Cao, Zhaosheng Ma, Zenggui Wu, Weizhu Wu, Ouchen Wang, Binbin Cui, Xiaotao Zhu, Jing Hao, Xiaochun Ji, Zhanwen Li, Deyou Tao, Qingjing Feng, Wei Lin, Dongbo Shi, Jingde Shu, Jichun Zhou, Shifen Huang
medRxiv 2024.09.05.24313095; doi: https://doi.org/10.1101/2024.09.05.24313095

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Oncology
Subject Areas
All Articles
  • Addiction Medicine (427)
  • Allergy and Immunology (753)
  • Anesthesia (220)
  • Cardiovascular Medicine (3281)
  • Dentistry and Oral Medicine (362)
  • Dermatology (274)
  • Emergency Medicine (478)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (1164)
  • Epidemiology (13338)
  • Forensic Medicine (19)
  • Gastroenterology (896)
  • Genetic and Genomic Medicine (5128)
  • Geriatric Medicine (479)
  • Health Economics (781)
  • Health Informatics (3252)
  • Health Policy (1137)
  • Health Systems and Quality Improvement (1189)
  • Hematology (427)
  • HIV/AIDS (1012)
  • Infectious Diseases (except HIV/AIDS) (14611)
  • Intensive Care and Critical Care Medicine (908)
  • Medical Education (475)
  • Medical Ethics (126)
  • Nephrology (521)
  • Neurology (4899)
  • Nursing (261)
  • Nutrition (725)
  • Obstetrics and Gynecology (879)
  • Occupational and Environmental Health (795)
  • Oncology (2515)
  • Ophthalmology (722)
  • Orthopedics (280)
  • Otolaryngology (346)
  • Pain Medicine (323)
  • Palliative Medicine (90)
  • Pathology (537)
  • Pediatrics (1297)
  • Pharmacology and Therapeutics (548)
  • Primary Care Research (554)
  • Psychiatry and Clinical Psychology (4189)
  • Public and Global Health (7482)
  • Radiology and Imaging (1701)
  • Rehabilitation Medicine and Physical Therapy (1010)
  • Respiratory Medicine (979)
  • Rheumatology (478)
  • Sexual and Reproductive Health (495)
  • Sports Medicine (424)
  • Surgery (545)
  • Toxicology (71)
  • Transplantation (235)
  • Urology (203)